Ethema Health Corporation
GRST · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $6 | $5 | $5 | $2 |
| % Growth | 12.6% | 10.9% | 148.1% | – |
| Cost of Goods Sold | $0 | $1 | $1 | $0 |
| Gross Profit | $6 | $5 | $4 | $2 |
| % Margin | 100% | 87.4% | 76% | 90.8% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $7 | $5 | $4 | $2 |
| SG&A Expenses | $7 | $5 | $4 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $1 | -$1 | $0 |
| Operating Expenses | $7 | $6 | $3 | $2 |
| Operating Income | -$1 | -$1 | $0 | $0 |
| % Margin | -22.2% | -10.1% | 10.1% | 0.1% |
| Other Income/Exp. Net | -$1 | $1 | -$0 | -$2 |
| Pre-Tax Income | -$2 | $1 | $0 | -$2 |
| Tax Expense | $0 | -$0 | $0 | -$0 |
| Net Income | -$2 | $1 | $0 | -$2 |
| % Margin | -34.3% | 22% | 5.1% | -79.4% |
| EPS | -0 | 0 | 0 | -0.001 |
| % Growth | -200% | 200% | 116.7% | – |
| EPS Diluted | -0 | 0 | 0 | -0.001 |
| Weighted Avg Shares Out | 7,207 | 3,729 | 3,705 | 2,702 |
| Weighted Avg Shares Out Dil | 7,207 | 3,904 | 3,705 | 2,702 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $1 | $3 |
| Depreciation & Amortization | $1 | $1 | $1 | $0 |
| EBITDA | -$1 | $2 | $2 | $1 |
| % Margin | -9.5% | 38.8% | 50.2% | 71.3% |